Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 328.67% is 105% above its 5-year average of -6514.01%, near the high end of its 5-year range (-14868.42%–328.67%).
3045.10% above its 12-month average of -11.16%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-03-31): 0.00%.
NET PROFIT MARGIN
328.67%
NET PROFIT MARGIN AVG TTM
-11.16%
NET PROFIT MARGIN AVG 3Y
-5795.47%
NET PROFIT MARGIN AVG 5Y
-6514.01%
NET PROFIT MARGIN AVG 10Y
-5724.04%
NET PROFIT MARGIN AVG 15Y
-5342.84%
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+3045.10%
CURRENT VS 3Y AVG
+105.67%
CURRENT VS 5Y AVG
+105.05%
CURRENT VS 10Y AVG
+105.74%
CURRENT VS 15Y AVG
+106.15%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.35%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
+94005.71%
vs the sector median at left
Traws Pharma, Inc.
Market Cap
$7.92M
Net Profit Margin
328.67%
TTM Avg
-11.16%
3Y Avg
-5795.47%
5Y Avg
-6514.01%
Market Cap
$7.87M
Net Profit Margin
0.00%
TTM Avg
-431.21%
3Y Avg
-828.00%
5Y Avg
-552.00%
Market Cap
$8.04M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$8.05M
Net Profit Margin
-1100.30%
TTM Avg
-235.88%
3Y Avg
-120.03%
5Y Avg
-120.03%
Market Cap
$7.75M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$8.14M
Net Profit Margin
N/A
TTM Avg
-206582.99%
3Y Avg
-143015.53%
5Y Avg
-102538.66%
Market Cap
$7.67M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$7.64M
Net Profit Margin
-4791.48%
TTM Avg
-2970.23%
3Y Avg
-7387.99%
5Y Avg
-5910.39%
Market Cap
$7.62M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Traws Pharma, Inc. (TRAW) | $7.92M | 328.67% | -11.16% | -5795.47% | -6514.01% |
| Aprea Therapeutics, Inc. (APRE)vs › | $7.87M | 0.00% | -431.21% | -828.00% | -552.00% |
| GT Biopharma, Inc. (GTBP)vs › | $8.04M | 0.00% | 0.00% | 0.00% | 0.00% |
| DataMEDS AI, Inc. (MEDS)vs › | $8.05M | -1100.30% | -235.88% | -120.03% | -120.03% |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.75M | 0.00% | 0.00% | 0.00% | 0.00% |
| HeartSciences Inc. (HSCS)vs › | $8.14M | N/A | -206582.99% | -143015.53% | -102538.66% |
| ENDRA Life Sciences Inc. (NDRA)vs › | $7.67M | 0.00% | 0.00% | 0.00% | 0.00% |
| Mangoceuticals, Inc. (MGRX)vs › | $7.64M | -4791.48% | -2970.23% | -7387.99% | -5910.39% |
| Quince Therapeutics, Inc. (QNCX)vs › | $7.62M | 0.00% | 0.00% | 0.00% | 0.00% |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.33M | -66.29% | -59.63% | -44.17% | -31.01% |
Operating Margin
-640.7%
Net Profit Margin
328.7%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-06-30 | -33.48% |
| 2024-12-31 | -14868.42% |
| 2024-06-30 | -8898.21% |
| 2023-12-31 | -7896.46% |
| 2023-06-30 | -8871.68% |
| 2022-12-31 | -9573.45% |
| 2022-06-30 | -7208.85% |
| 2021-12-31 | -6386.73% |
| 2021-06-30 | -7916.81% |
| 2020-12-31 | -10300.81% |
| 2020-06-30 | -11562.04% |
| 2019-12-31 | -11120.43% |
| 2019-06-30 | -534.02% |
| 2018-12-31 | -6144.69% |
| 2018-06-30 | -912.68% |
| 2017-12-31 | -5204.74% |
| 2017-06-30 | -2045.88% |
| 2016-12-31 | -386.29% |
| 2016-06-30 | -339.09% |
| 2015-12-31 | -23.90% |
| 2015-06-30 | -8986.50% |
| 2014-12-31 | -12390.35% |
| 2014-06-30 | -6194.41% |
| 2013-12-31 | -1153.51% |
| 2013-06-30 | -1605.57% |
| 2012-12-31 | -25.55% |
| 2012-06-30 | -4357.66% |